Published by Josh White on 28th June 2019
(Sharecast News) - Specialist drug discovery and development company ImmuPharma released the analysis of results from the open-label six month extension study from its original pivotal phase 3 trial of 'Lupuzor' on Friday.
URL: http://www.digitallook.com/dl/news/story/29233335/...